Insider Trading disclosures for Solid Biosciences Inc

The latest disclosure was made by Clare Kahn in Solid Biosciences Inc where a trade of 1,860 Common Stock done at an average price of $5.3 was reported to US exchanges on March 11, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Clare Kahn	Director	Purchase of securities on an exchange or from another person at price $ 5.34 per share.	11 Mar 2025	1,860	2,960 (0%)	0%	5.3	9,924	Common Stock
David Tyronne Howton	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Feb 2025	14,687	30,350 (0%)	0%		-	Common Stock
David Tyronne Howton	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 3.96 per share.	13 Feb 2025	5,561	24,789 (0%)	0%	4.0	22,022	Common Stock
David Tyronne Howton	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Feb 2025	14,687	44,063	-		-	Restricted Stock Units
Alexander G. Cumbo	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 3.96 per share.	13 Feb 2025	11,365	60,717 (0%)	0%	4.0	45,005	Common Stock
Alexander G. Cumbo	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Feb 2025	30,031	90,094	-		-	Restricted Stock Units
Alexander G. Cumbo	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Feb 2025	30,031	72,082 (0%)	0%		-	Common Stock
Ilan Ganot	Director	Sale of securities on an exchange or to another person at price $ 3.96 per share.	13 Feb 2025	1,711	14,839 (0%)	0%	4.0	6,776	Common Stock
Ilan Ganot	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Feb 2025	4,861	16,550 (0%)	0%		-	Common Stock
Ilan Ganot	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Feb 2025	4,861	14,583	-		-	Restricted Stock Units
Kevin Tan	CFO & Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Feb 2025	10,625	35,414 (0%)	0%		-	Common Stock
Kevin Tan	CFO & Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Feb 2025	10,625	31,875	-		-	Restricted Stock Units
Kevin Tan	CFO & Treasurer	Sale of securities on an exchange or to another person at price $ 3.96 per share.	13 Feb 2025	3,164	32,250 (0%)	0%	4.0	12,529	Common Stock
Paul Herzich	Chief Technology Officer	Sale of securities on an exchange or to another person at price $ 3.96 per share.	13 Feb 2025	2,688	18,388 (0%)	0%	4.0	10,644	Common Stock
Paul Herzich	Chief Technology Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Feb 2025	7,187	21,076 (0%)	0%		-	Common Stock
Paul Herzich	Chief Technology Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Feb 2025	7,187	21,563	-		-	Restricted Stock Units
Jessie Hanrahan	Chief Regulatory Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Feb 2025	8,125	22,360 (0%)	0%		-	Common Stock
Jessie Hanrahan	Chief Regulatory Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Feb 2025	8,125	24,375	-		-	Restricted Stock Units
Jessie Hanrahan	Chief Regulatory Officer	Sale of securities on an exchange or to another person at price $ 3.96 per share.	13 Feb 2025	3,079	19,281 (0%)	0%	4.0	12,193	Common Stock
Gabriel Brooks	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Feb 2025	10,937	32,813	-		-	Restricted Stock Units
Gabriel Brooks	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Feb 2025	10,937	26,068 (0%)	0%		-	Common Stock
Gabriel Brooks	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 3.96 per share.	13 Feb 2025	3,256	22,812 (0%)	0%	4.0	12,894	Common Stock
David Tyronne Howton	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2025	169,100	169,100	-		-	Restricted Stock Units
Alexander G. Cumbo	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2025	401,600	401,600	-		-	Restricted Stock Units
Ilan Ganot	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2025	60,000	60,000	-		-	Restricted Stock Units
Kevin Tan	CFO & Treasurer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2025	132,300	132,300	-		-	Restricted Stock Units
Paul Herzich	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2025	98,700	98,700	-		-	Restricted Stock Units
Jessie Hanrahan	Chief Regulatory Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2025	110,500	110,500	-		-	Restricted Stock Units
Gabriel Brooks	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2025	112,900	112,900	-		-	Restricted Stock Units
Ilan Ganot	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Jan 2025	388	11,833 (0%)	0%		-	Common Stock
Ilan Ganot	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Jan 2025	3,883	3,884	-		-	Restricted Stock Units
Ilan Ganot	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Jan 2025	388	389	-		-	Restricted Stock Units
Ilan Ganot	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	27 Jan 2025	3,883	98,690 (0%)	0%		-	Common Stock
Ilan Ganot	Director	Sale of securities on an exchange or to another person at price $ 3.11 per share.	27 Jan 2025	144	11,689 (0%)	0%	3.1	448	Common Stock
Kevin Tan	CFO & Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Jan 2025	11,250	28,862 (0%)	0%		-	Common Stock
Kevin Tan	CFO & Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Jan 2025	11,250	22,500	-		-	Restricted Stock Units
Kevin Tan	CFO & Treasurer	Sale of securities on an exchange or to another person at price $ 3.89 per share.	09 Jan 2025	4,073	24,789 (0%)	0%	3.9	15,849	Common Stock
Ian F. Smith	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Jan 2025	3,255	112,972 (0%)	0%		-	Common Stock
Ian F. Smith	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Jan 2025	3,255	0	-		-	Restricted Stock Units
Ian F. Smith	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2025	22,148	22,148	-		-	Stock Option (Right to Buy)
Ian F. Smith	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2025	18,293	18,293	-		-	Restricted Stock Units
Ilan Ganot	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Jan 2025	2,994	12,501 (0%)	0%		-	Common Stock
Ilan Ganot	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Jan 2025	2,994	5,988	-		-	Restricted Stock Units
Ilan Ganot	Director	Sale of securities on an exchange or to another person at price $ 4.31 per share.	03 Jan 2025	1,056	11,445 (0%)	0%	4.3	4,551	Common Stock
Tyronne David Howton	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Dec 2024	13,051	26,103	-		-	Restricted Stock Units
Jessie Hanrahan	Chief Regulatory Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Dec 2024	11,862	23,725	-		-	Restricted Stock Units
Tyronne Howton David	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 5.60 per share.	02 Dec 2024	5,072	15,663 (0%)	0%	5.6	28,396	Common Stock
Paul Herzich	Chief Technology Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Dec 2024	7,239	14,959 (0%)	0%		-	Common Stock
Jessie Hanrahan	Chief Regulatory Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Dec 2024	11,862	18,845 (0%)	0%		-	Common Stock
G. Alexander Cumbo	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Dec 2024	28,612	57,225	-		-	Restricted Stock Units

Showing 1 to 50 of 381 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

69.44% Fall from 52W High

Insider Trading disclosures for Solid Biosciences Inc

The latest disclosure was made by Clare Kahn in Solid Biosciences Inc where a trade of 1,860 Common Stock done at an average price of $5.3 was reported to US exchanges on March 11, 2025.

Screeners based on Insider Trading and SAST parameters